When.com Web Search

  1. Ads

    related to: car t therapy toxicity

Search results

  1. Results From The WOW.Com Content Network
  2. FDA says cancer treatment CAR-T therapy may increase ... - AOL

    www.aol.com/news/fda-says-cancer-treatment-car...

    CAR-T — or chimeric antigen receptor T cell — therapy uses a patient’s own immune cells to treat certain blood cancers, such as leukemia, multiple myeloma and lymphoma. It involves ...

  3. US FDA investigating safety risk of CAR-T cancer therapies - AOL

    www.aol.com/news/us-fda-investigating-safety...

    Dr. Julie Gralow, chief medical officer of the American Society of Clinical Oncology, said, “Based on the available data, the risk of T-cell malignancies due to CAR-T cell therapy appears to be ...

  4. CAR T cell - Wikipedia

    en.wikipedia.org/wiki/CAR_T_cell

    Depiction of adoptive cell transfer therapy with CAR-engineered T cells. The first step in the production of CAR T-cells is the isolation of T cells from human blood. CAR T-cells may be manufactured either from the patient's own blood, known as an autologous treatment, or from the blood of a healthy donor, known as an allogeneic treatment. The ...

  5. Cellular adoptive immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cellular_adoptive...

    CAR-T therapy exhibits distinct specificity compared to other adaptive immunotherapies and traditional cancer treatments such as chemotherapy. [8] CAR-T kill tumor cells specifically by targeting the tumor-associated antigens to keep the damage to healthy tissue at a minimum level.

  6. FDA says cancer treatment CAR-T therapy may cause ... - AOL

    www.aol.com/fda-says-cancer-treatment-car...

    A new labeling requirement comes months after the FDA investigated reports that users of the specialized therapies were getting T-cell malignancies. FDA says cancer treatment CAR-T therapy may ...

  7. Engineered CAR T cell delivery - Wikipedia

    en.wikipedia.org/wiki/Engineered_CAR_T_cell_delivery

    Engineered chimeric antigen receptor (CAR)-T cell delivery is the methodology by which clinicians introduce the cancer-targeting therapeutic system of the CAR-T cell to the human body. CAR-T cells, which utilizes genetic modification of human T-cells to contain antigen binding sequences in addition to the receptor systems CD4 or CD8 , are ...